Hepcidin mRNA acts locally at the tumor level, promoting metastatic potential, whereas hepcidin-25 has a systemic action, in response to the progression of renal cell carcinoma. The gene discussed is HAMP; the disease is hereditary clear cell renal cell carcinoma.